KA/EN
Register
Medicines reference
Search
Search
Active substance

Glucosamine

Favourites

Aminosaccharide. Registered in Georgia: 2 veterinary products. Forms: capsule, scored tablet.

Dose and use

Doses

We have no dose with a cited source for this substance yet.

Before use

Safety information

No sourced safety entry is currently shown. This does not mean the substance is risk-free.

Latin name
Glucosamine
Georgian name
გლუკოზამინი
Authorisation status
Complementary feed / supplement
Not a medicine and not required to be authorised as one - it is sold under feed law.
Registered in Georgia
2 of 4 forms
Products
Artrin, Artrin Plus, Urinovet Cat, Urinovet Cat Dilution
Human medicines in Georgia
Dona, Ostedon, Rotadon, Sinarta, Soludon
Human medicines with this substance in the Georgian register of medicines (Ministry of Health), checked on 18 Oct 2026. They are human medicines, not veterinary products; strengths and forms differ.
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
All forms and registration4

Registration in Georgia and abroad: the register, number, validity and source are behind (i).

Artrin 500/100/10 mg palatable scored tablets, Scored tablet

N30 for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
4.7/10
Weak evidence support
vetman assessment

Artrin

500/100/10 mg palatable scored tablets, N30 for dogs
Assessed clinical scopeDog · Full dog label: glucosamine, chondroitin sulfate and manganese chewable tablets as joint support in degenerative joint disease and osteoarthritis · oral
Care settingLong-term home use as an optional add-on to weight control, exercise management and proven analgesia
vetman score 4.7/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000894 · Verified on 21 Oct 2026

A weak option: a joint-support product with little proof of benefit and limited exact-product safety evidence. Base osteoarthritis care on weight control, exercise and proven analgesics such as NSAIDs.

Regulatory and scientific credibility4.0/10

The N30 dog presentation is registered in Georgia (000894, valid to 2030) with the Argentine maker's leaflet, but no EU, UK or US authorisation was documented in the reviewed evidence or product study, and claims rest on manufacturer material.

Clinical efficacy3.0/10

Systematic reviews and pain guidelines find weak or inconsistent evidence that glucosamine and chondroitin improve pain or function in canine osteoarthritis; a fixed one tablet above 15 kg also gives large dogs a low dose per kg.

Safety and tolerability6.0/10

The manufacturer leaflet lists pregnancy, lactation and phenylketonuria exclusions and possible antibiotic-absorption interactions, but no exact-product tolerability study or quantified adverse-event dataset was found.

Clinical practicality6.5/10

A palatable scored tablet once daily (half below 15 kg, one above) for at least 6 weeks is easy, but the leaflet leaves exactly 15 kg unassigned.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use during pregnancy or lactation, in phenylketonuria or with hypersensitivity to a component.
  • Glucosamine can increase tetracycline absorption and reduce chloramphenicol and penicillin absorption.
  • Not an analgesic: dogs with osteoarthritis pain need proven pain control.
  • One tablet is the dose for every dog above 15 kg, so large dogs get a low dose per kg; no dose is set for exactly 15 kg.
  • Judge response after the minimum 6-week course and stop if there is no clear benefit.
Assessment sources
  1. Brouwer label
  2. Georgia NFA register 20262026
  3. WSAVA pain guideline2023
  4. AAHA Pain Guidelines 20222022
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Glucosamine500 mg/tablet Chondroitin sulfate100 mg/tablet Manganese10 mg/tablet
Formulation Type
Scored tablet
Administration route
oral
Manufacturer
Brouwer S.A. · Argentina
Manufacturer (register)
BROUWER S.A., Argentina
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1438, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 14 Jul 2030
Veterinary (National Food Agency)
In the register: ართრინი
№ 000894
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

Artrin Plus 110/500/100/10 mg palatable scored tablets, Scored tablet

N18 for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.1/10
Weak evidence support
vetman assessment

Artrin Plus

110/500/100/10 mg palatable scored tablets, N18 for dogs
Assessed clinical scopeDog · Full dog label from 3 kg: carprofen 110 mg with glucosamine, chondroitin and manganese for short courses of pain and inflammation in osteoarticular disease · oral
Care settingVeterinary-prescribed NSAID course after examination and risk screening, with weight-checked dosing
vetman score 5.1/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000892 · Verified on 21 Oct 2026

A weak option: the carprofen works, but the coarse weight bands can roughly double the standard dose in small dogs and the added nutraceuticals bring no proven benefit. A single-agent, accurately dosed carprofen product is safer.

Regulatory and scientific credibility5.0/10

The N18 dog presentation is registered in Georgia (000892, valid to 2030) with the Argentine maker's leaflet; carprofen itself is EU-authorised for dogs with strong independent evidence, but this fixed combination has no EU, UK or US authorisation documented in the reviewed evidence or product study.

Clinical efficacy6.0/10

Carprofen reliably reduces osteoarthritis pain and inflammation in dogs; the glucosamine and chondroitin add no proven benefit, least of all over an 8-day course.

Safety and tolerability4.0/10

Weight bands give up to about 9 mg/kg carprofen at 3 kg and about 7 mg/kg at 8 kg, roughly double the usual 4 mg/kg daily dose; NSAID gastrointestinal, renal and hepatic risks apply and the leaflet leaves dose gaps at 7.5-8 kg and 15 kg.

Clinical practicality5.5/10

A palatable scored tablet once daily is easy to give, but quarter-tablet splitting and coarse bands make accurate dosing hard in small dogs.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not give to cats. Do not use in dogs with gastric ulcer, phenylketonuria or hypersensitivity to a component.
  • Weigh the dog: at the light end of each band the carprofen dose is well above 4 mg/kg (about 9 mg/kg at 3 kg); prefer an accurately dosed carprofen product in small dogs. No dose is set for 7.5-8 kg or exactly 15 kg.
  • Do not combine with other NSAIDs or glucocorticoids; allow a washout when switching.
  • Dehydration, renal, hepatic, cardiovascular or gastrointestinal disease, coagulation disorders, hypoproteinaemia and pregnancy need a benefit-risk decision before use.
  • Stop and seek veterinary advice for vomiting, dark stools, anorexia, lethargy, jaundice or changes in thirst or urination; check kidney and liver values in at-risk or older dogs.
Assessment sources
  1. Brouwer label
  2. Georgia NFA register 20262026
  3. WSAVA pain guideline2023
  4. AAHA Pain Guidelines 20222022
  5. MSD Vet Manual 20242024
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Carprofen110 mg/tablet Glucosamine500 mg/tablet Chondroitin sulfate100 mg/tablet Manganese10 mg/tablet
Formulation Type
Scored tablet
Administration route
oral
Manufacturer
Brouwer S.A. · Argentina
Manufacturer (register)
BROUWER S.A, Argentina
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1436, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 14 Jul 2030
Veterinary (National Food Agency)
In the register: ართრინ პლუსი
№ 000892
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

Urinovet Cat, Capsule

capsule, VetExpert
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
4.5/10
Weak evidence support
vetman assessment

Urinovet Cat

capsule, VetExpert
Assessed clinical scopeCat · Optional adjunct inside a diagnosis-specific multimodal feline lower-urinary-tract plan; not obstruction, UTI, stone dissolution or FIC monotherapy · By mouth
Care settingVeterinarian-directed outpatient adjunct with diagnosis-specific selection, exact-form administration and objective laboratory reassessment.
vetman score 4.5/10 Weak evidence support
Evidence confidence: Low Georgia: Not a medicine · Verified on 15 Oct 2026

A convenient feline urinary supplement whose key claims are not supported by strong clinical evidence; it cannot replace diagnosis, water/environment management, analgesia or culture-directed care.

Regulatory and scientific credibility4.0/10

Exact current composition, pack, category and schedule are transparent, but no independent exact-product outcome or regulator-reviewed target-animal safety dossier was located.

Clinical efficacy2.5/10

Controlled feline evidence does not show significant benefit from oral glycosaminoglycan-related therapy in FIC, cranberry clinical prevention is inconsistent, and no exact-product outcome study was located.

Safety and tolerability5.0/10

No exact feline repeated-dose safety study exists. Ingredients are generally low-risk but valerian sedation, parsley-related fluid balance, animal-derived glucosamine sensitivity, GI effects and interactions remain unquantified.

Clinical practicality8.0/10

One whole TWIST OFF capsule daily gives good dose-unit fit, although medicating stress can be counterproductive in FIC and no convenience advantage establishes efficacy.

Full-course cost-effectiveness-

No verified current Georgian patient-adjusted course price or evidence-based exact-product duration is available, so cost is excluded.

Important safety and use flags

  • Complementary feed, not a medicine. Medicine-authorisation status is not applicable; category status is not evidence of efficacy or regulator-reviewed safety.
  • Lower-urinary-tract signs require diagnosis. This product does not treat urethral obstruction, replace analgesia, dissolve every stone or substitute for culture-directed UTI care.
  • Controlled feline evidence found no significant FIC benefit from oral glucosamine-related therapy, and cranberry clinical prevention evidence is inconsistent. No exact-product outcome study was located.
  • Cranberry/glucosamine/parsley/valerian mechanisms do not establish treatment of sterile FIC or bacterial UTI; do not infer efficacy from ingredient presence.
  • Use the intended TWIST OFF capsule by opening/squeezing it; do not substitute another capsule, estimate a partial content dose or assume formulation equivalence.
  • For FIC, prioritise multimodal environmental modification, water intake and analgesia. Oral administration stress can itself undermine the plan.
  • No exact-product feline clinical outcome, recurrence, PK, dose-ranging or repeated-dose safety study was located.
  • Review every concurrent medicine, diet and supplement for duplicated ingredients, binding, sedation, GI effects and disease-specific contraindications; exact interaction magnitude is unknown.
  • Track the diagnosed cause, pain, urination pattern, water intake, urinalysis/culture and imaging as appropriate. Stop if no predefined objective benefit appears.
  • Exact safety in pregnancy, lactation, breeding animals, kittens/puppies and long-term severe renal, hepatic or multisystem disease is not established; use only after explicit individual benefit-risk review.
Assessment sources
  1. VetExpert Urinovet Cat2026
  2. iCatCare feline LUTD 20252025
  3. FIC glucosamine RCT2004
  4. ISCAID UTI2019
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Cranberry Extract125 mg Glucosamine84 mg
Formulation Type
Capsule
Administration route
By mouth
Manufacturer
Vet Planet Sp. z o.o. (VetExpert) · Poland
Registration
Georgia Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
 EU Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
 UK Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
 US Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified Label schedule: one TWIST OFF capsule per cat once daily. This does not establish treatment of obstruction, infection, stones or FIC; use only inside a diagnosis-specific multimodal plan.

Urinovet Cat Dilution, Capsule

capsule, VetExpert
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
4.2/10
Weak evidence support
vetman assessment

Urinovet Cat Dilution

capsule, VetExpert
Assessed clinical scopeCat · Additional urine acidification only for confirmed, monitored struvite-risk physiology when individually justified; not undifferentiated LUT signs, FIC, UTI, calcium-oxalate disease or obstruction · By mouth
Care settingVeterinarian-directed outpatient adjunct with diagnosis-specific selection, exact-form administration and objective laboratory reassessment.
vetman score 4.2/10 Weak evidence support
Evidence confidence: Low Georgia: Not a medicine · Verified on 15 Oct 2026

A convenient but potentially consequential acidifying blend with no exact outcome trial or titration target; restrict it to confirmed monitored struvite-risk cases and avoid duplicate acidification.

Regulatory and scientific credibility4.0/10

Exact current composition, pack, category and schedule are transparent, but no independent exact-product outcome or regulator-reviewed target-animal safety dossier was located.

Clinical efficacy3.5/10

Urine acidification can contribute to a confirmed struvite plan, but the exact fixed blend lacks a pH-targeted trial and is not indicated for common non-obstructive FIC; cranberry/glucosamine evidence is weak.

Safety and tolerability3.5/10

Fixed acidifier exposure without a published target or titration algorithm can cause excessive acidification, metabolic/mineral disturbance or inappropriate use in calcium-oxalate disease and CKD; exact safety data are absent.

Clinical practicality7.0/10

Two TWIST OFF capsules/day can be divided morning/evening, but safe use requires baseline diagnosis and repeated urine pH, sediment and stone assessment rather than unsupervised long-term use.

Full-course cost-effectiveness-

No verified current Georgian patient-adjusted course price or evidence-based exact-product duration is available, so cost is excluded.

Important safety and use flags

  • Complementary feed, not a medicine. Medicine-authorisation status is not applicable; category status is not evidence of efficacy or regulator-reviewed safety.
  • Lower-urinary-tract signs require diagnosis. This product does not treat urethral obstruction, replace analgesia, dissolve every stone or substitute for culture-directed UTI care.
  • Use only for confirmed monitored struvite-risk physiology. Acidification is generally not indicated for non-obstructive FIC and the exact product has no dissolution or recurrence trial.
  • Never combine blindly with another strongly acidifying product or diet. The exact label carries this warning.
  • Two capsules provide 500 mg DL-methionine and 150 mg vitamin C per cat/day without a published pH target, titration algorithm or maximum duration. Do not treat this as a universal feline dose.
  • Serial urine pH, sediment and imaging are required. Stop for excessive acidification, metabolic acidosis, calcium-oxalate risk, GI intolerance or worsening renal/mineral status.
  • No exact-product feline clinical outcome, recurrence, PK, dose-ranging or repeated-dose safety study was located.
  • Review every concurrent medicine, diet and supplement for duplicated ingredients, binding, sedation, GI effects and disease-specific contraindications; exact interaction magnitude is unknown.
  • Track the diagnosed cause, pain, urination pattern, water intake, urinalysis/culture and imaging as appropriate. Stop if no predefined objective benefit appears.
  • Exact safety in pregnancy, lactation, breeding animals, kittens/puppies and long-term severe renal, hepatic or multisystem disease is not established; use only after explicit individual benefit-risk review.
Assessment sources
  1. VetExpert Cat Dilution2026
  2. iCatCare feline LUTD 20252025
  3. ISCAID UTI2019
  4. Feline acidification study2021
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
DL-Methionine250 mg Ascorbic Acid75 mg Pyridoxine3 mg Cranberry Extract31 mg Glucosamine21 mg
Formulation Type
Capsule
Administration route
By mouth
Manufacturer
Vet Planet Sp. z o.o. (VetExpert) · Poland
Registration
Georgia Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
 EU Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
 UK Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
 US Not a medicine
Not applicable (not a medicine)
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified Label schedule: two TWIST OFF capsules per cat daily; the daily amount may be divided morning and evening. Use only for confirmed, monitored struvite-risk physiology when extra acidification is justified; do not combine with another strongly acidifying product or diet.

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗